President and CEO of ONCOGENEX PHARMACEUTICALS INC. - COMMON SHARES (OGXI, Financial) Scott Daniel Cormack sells 5,000 shares of OGXI on 12/01/2010 at an average price of $16.02 a share.
Oncogenex Pharmaceuticals Inc. - Common Shares has a market cap of $103.1 million; its shares were traded at around $16 with and P/S ratio of 4.1.
OGXI is in the portfolios of Jean-Marie Eveillard of First Eagle Investment Management, LLC, Jim Simons of Renaissance Technologies LLC.
Oncogenex Pharmaceuticals Inc. - Common Shares has a market cap of $103.1 million; its shares were traded at around $16 with and P/S ratio of 4.1.
OGXI is in the portfolios of Jean-Marie Eveillard of First Eagle Investment Management, LLC, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: President and CEO Scott Daniel Cormack sold 5,000 shares of OGXI stock on 11/15/2010 at the average price of 15.99. Scott Daniel Cormack owns at least 51,839 shares after this. The price of the stock has increased by 0.06% since.
- Sell: President and CEO Scott Daniel Cormack sold 5,000 shares of OGXI stock on 11/01/2010 at the average price of 15.45. Scott Daniel Cormack owns at least 46,839 shares after this. The price of the stock has increased by 3.56% since.
Directors and Officers Recent Trades:
- Buy: Principal Financial Officer Cameron William Lawrence bought 650 shares of OGXI stock on 11/09/2010 at the average price of 15.73. Cameron William Lawrence owns at least 3,525 shares after this. The price of the stock has increased by 1.72% since.
- Sell: Former Director Michael A Martino sold 2,557 shares of OGXI stock on 07/06/2010 at the average price of 13.02. Michael A Martino owns at least 11,000 shares after this. The price of the stock has increased by 22.89% since.
